FDA
-
-
-
-
-
-
-
Prime Medicine (PRME) Reiterated at Market Outperform by Citizens on AATD, WD Interest
-
-
-
-
-
-
-
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
-
-
-
-
-
-
-
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
327,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

